RXO Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
115.2mn → 168.5mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
+31.1% YoY in FY25 · 1.0% of revenue.
$1.0M returned vs $−8.0M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.
-2¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Over this window: gross 21.5% → 19.7%. Net margin -1.7% is below the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 6,539.0 | 5,742.0 | 4,550.0 | 3,927.0 | 4,796.0 | 4,689.0 | ▲26.2% | +5.2% |
Cost of revenue | 5,384.0 | 4,611.0 | 3,565.0 | 2,967.0 | 3,624.0 | 3,681.0 | ▲29.3% | +5.8% |
Gross profit | 1,155.0 | 1,131.0 | 985.0 | 960.0 | 1,172.0 | 1,008.0 | ▲14.8% | +2.9% |
Selling, general & admin | 831.0 | 832.0 | 666.0 | 591.0 | 640.0 | 539.0 | ▲24.9% | +11.5% |
Total operating expenses | 1,207.0 | 1,210.0 | 1,041.0 | 921.0 | 1,049.0 | 816.0 | ▲16.2% | +10.4% |
Operating incomefeeds ROC rank | −52.0 | −79.0 | −56.0 | 39.0 | 123.0 | 192.0 | ▼41.1% | — |
Other income, net | −50.0 | −36.0 | −248.0 | −35.0 | −4.0 | −1.0 | — | — |
Pretax income | −102.0 | −115.0 | −304.0 | 4.0 | 119.0 | 191.0 | ▲62.2% | — |
Income tax | −14.0 | −15.0 | −14.0 | 0.0 | 27.0 | 41.0 | ▼7.1% | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −88.0 | −100.0 | −290.0 | 4.0 | 92.0 | 150.0 | ▲65.5% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.52 | −0.59 | −2.17 | 0.03 | 0.79 | 1.30 | ▲72.8% | — |
Diluted shares (mn) | 172.01 | 168.46 | 133.41 | 119.46 | 115.79 | 115.16 | ▲26.3% | +10.0% |
| Margins | ||||||||
Gross margin13th pct in Industrials | 17.7% | 19.7% | 21.6% | 24.4% | 24.4% | 21.5% | ▼2.0pp | −1.8pp |
Operating margin | −0.8% | −1.4% | −1.2% | 1.0% | 2.6% | 4.1% | ▼0.1pp | −5.5pp |
Net margin8th pct in Industrials | −1.3% | −1.7% | −6.4% | 0.1% | 1.9% | 3.2% | ▲4.6pp | −4.9pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was RXO's revenue last fiscal year?
RXO reported revenue of $5,742.0M in fiscal 2025, up 26.2% from fiscal 2024.
What was RXO's net income?
RXO reported net income of −$100.0M in fiscal 2025, a net margin of −1.7%.

